PF-00489791 has been used in trials studying the treatment of Hypertension, Raynaud's Disease, Diabetic Nephropathies, Hypertension, Pulmonary, and Peripheral Vascular Disease.
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.